Time filter

Source Type

Castellana Grotte, Italy

Valerio F.,CNR Institute of Sciences of Food Production | Russo F.,Laboratory of Experimental Biochemistry | De Candia S.,CNR Institute of Sciences of Food Production | Riezzo G.,National Institute of Digestive Diseases | And 3 more authors.
Journal of Clinical Gastroenterology | Year: 2010

Goals: To determine whether the consumption of artichokes enriched with a probiotic Lactobacillus paracasei strain affects fecal microbiota composition, fecal enzyme activity, and short-chain fatty acids production and symptom profile in patients suffering from constipation. Background: Constipation is a common gastrointestinal disorder often related to the food diet. The beneficial effects of probiotics and prebiotics on human health are under investigation. Moreover, recent studies assessed the suitability of some vegetables, particularly olives and artichokes, to vehicle probiotic strains into the gastrointestinal tract. Study: For 15 days, 8 volunteers (3M/5F age 40a±14y) integrated their normal diet with artichokes (180gr) enriched with 20 billions of L. paracasei LMGP22043. Faecal samples were subjected to microbiologic and biochemical analyses. Besides, investigations on symptom profile of the volunteers and stool consistency were carried out by using a validated questionnaire (Gastrointestinal Symptom Rating Scale) and the Bristol stool form chart. Results: The gut of all volunteers resulted to be colonized by the probiotic strain after 15 days feeding. No significant differences in the microbiological counts throughout the experimental period were registered, whereas a significant increase of butyric and valeric acids with a concomitant decrease of lactic acid was registered. At the same time, the fecal ?β-glucuronidase activity was significantly reduced. Finally, the analysis of symptom profile indicated a marked reduction in abdominal distension and feeling of incomplete evacuation. Conclusions: These preliminary data suggest that novel approaches for treating constipation can come through ingestion of probiotic vegetable products that, acting as symbiotics, can ameliorate this common disorder. Copyright © 2010 by Lippincott Williams & Wilkins.

Russo F.,Laboratory of Experimental Biochemistry | Clemente C.,Laboratory of Experimental Biochemistry | Linsalata M.,Laboratory of Experimental Biochemistry | Chiloiro M.,Laboratory of Experimental Pathophysiology | And 4 more authors.
European Journal of Nutrition | Year: 2011

Aim Our group has previously shown that the administration of pasta enriched along with the prebiotic inulin induces a significant reduction in triglyceride and glucose levels with a significant delay in gastric emptying (GE) rates. This protective effect may occur by affecting the release of a number of gut peptides involved in the control of gastrointestinal motility. The aim of the present study was to evaluate the effects of inulin-enriched pasta on the circulating levels of neurotensin (NT), somatostatin (SS), and corticotropin-releasing factor (CRF) in relation to the GE time in young healthy subjects. Methods Twenty healthy young male volunteers completed a randomized double-blind crossover study consisting of a 2-week run-in period and two 5-week study periods (11% inulin-enriched/control pasta), with an 8-week wash-out period in between. Gut peptide concentrations were evaluated by radioimmunoassay. GE time was evaluated by ultrasonography. Results The prebiotic treatment significantly increased the area under the curve (AUC) values of both NT and SS (p<0.05 Dunn's post-test). With regard to gastric motility, along with a significant delay in both the final time and T1/2 gastric emptying time, a positive correlation was found between T1/2 and SS AUC values (r = 0.57, p = 0.009) in the inulin-enriched pasta group. Conclusion These results support the hypothesis that inulin plays an active role in mechanisms affecting the release of these gut peptides, which may modulate the gastric emptying of digesta. © Springer-Verlag 2010.

Russo F.,Laboratory of Experimental Biochemistry | Riezzo G.,National Institute For Digestive Diseases Irccs Saverio Of Bellis | Chiloiro M.,National Institute For Digestive Diseases Irccs Saverio Of Bellis | De Michele G.,National Institute For Digestive Diseases Irccs Saverio Of Bellis | And 5 more authors.
Current Pharmaceutical Design | Year: 2010

Different lines of evidence suggest that higher intake of fiber may somehow protect against metabolic syndrome. The prebiotic inulin has widely been studied in relation to its putative beneficial effects on lipid and glucose metabolism. Therefore, adding inulin to diet may be a suitable strategy to prevent metabolic syndrome. Aim of the present study was to evaluate the effects of the daily consumption of inulin-enriched pasta on lipid and glucose metabolism as well as on gastrointestinal motility in young healthy subjects. Methods. Twenty-two healthy young male volunteers entered a randomized double blind cross-over study consisting of a 2-weeks run-in period, two 5-weeks study periods (11% inulin-enriched or control pasta), and an 8-weeks wash-out period in between. Serum lipid and glucose concentrations were evaluated by routine biochemical analyses. Gastric emptying time and electrical activity were non-invasively evaluated by ultrasound and electrogastrography. Data were analyzed by Friedman Repeated Measures ANOVA test. Results. Significant differences among baseline and the treatment group were found for HDL-cholesterol (p=0.004), total cholesterol/HDL-cholesterol ratio (p=0.006), triglycerides (p=0.04), fasting glucose level (p=0.044), fructosamine (p=0.0478), HbA1c (p=0.04), and homeostatic model assessment (HOMA-IR) (p=0.045). The gastric emptying, expressed as final emptying time, was found significantly delayed in the group that assumed inulin-enriched pasta (p=0.008). Conclusions. Inulin-enriched pasta improved lipidic and glicidic metabolism as well as the insulin resistance in healthy young subjects. In addition, it delayed the gastric emptying time which may represent the physiological counterpart of its metabolic effects. © 2010 Bentham Science Publishers Ltd.

Discover hidden collaborations